AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
On May 20, 2025, IQVIA's trading volume reached $663 million, marking a 51.07% increase from the previous day and ranking 112th in the day's trading volume. IQVIA's stock price rose by 0.98%, marking the third consecutive day of gains, with a total increase of 3.22% over the past three days.
IQVIA, a clinical research company, reported its first-quarter 2025 results, exceeding revenue expectations with a 2.5% year-on-year increase to $3.83 billion. The company's net profit surged by 80.7% due to strategic growth initiatives. IQVIA's performance was driven by real-world evidence, which has become a key factor in its outperformance amidst sector uncertainty.
Market Watch column provides a thorough analysis of stock market fluctuations and expert ratings.

Dec.30 2025

Dec.30 2025

Dec.29 2025

Dec.26 2025

Dec.26 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet